Bishton MJ, Hicks RJ, Westerman DA, Prince MH, Wolf M, Seymour JF. A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin’s lymphoma following treatment with iodine-131-rituximab radio-immunotherapy. Haematologica [Internet]. 2008Apr.30 [cited 2026Nov.13];93(5):789-90. Available from: https://haematologica.org/article/view/4858